Insulin antibody responses with insulin lispro in long term studies in patients with type 1 or type 2 diabetes

被引：0
|
作者：
Brunelle, RL
Huang, J
Fineberg, SE
Anderson, JH
机构：
来源：
DIABETOLOGIA | 1999年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
358
引用
收藏
页码：A98 / A98
页数：1
相关论文
共 50 条
  • [1] Effect of long-term exposure to insulin lispro on the induction of antibody response in patients with type 1 or type 2 diabetes
    Fineberg, SE
    Huang, J
    Brunelle, R
    Gulliya, KS
    Anderson, JH
    DIABETES CARE, 2003, 26 (01) : 89 - 96
  • [2] Modeling long term insulin/insulin lispro antibody measurements by age group and diabetes type
    Brunelle, R
    Huang, J
    Fineberg, SE
    Roach, P
    Anderson, JH
    DIABETOLOGIA, 2000, 43 : A199 - A199
  • [3] Long term monitoring of insulin antibody responses in patients treated with insulin lispro (Humalog)
    Huang, J
    Brunelle, RL
    Fineberg, E
    Anderson, JH
    DIABETES, 1999, 48 : A94 - A95
  • [4] A direst comparison of insulin aspart and insulin lispro in patients with type 1 diabetes
    Plank, J
    Wutte, A
    Brunner, G
    Siebenhofer, A
    Semlitsch, B
    Sommer, R
    Hirschberger, S
    Pieber, TR
    DIABETES CARE, 2002, 25 (11) : 2053 - 2057
  • [5] Insulin lispro for the treatment of type 2 diabetes
    Fisher, M
    HOSPITAL MEDICINE, 1999, 60 (11): : 802 - 806
  • [6] Long-term effectiveness of insulin lispro in subjects with type 1 diabetes treated with CSII
    Hermans, MP
    Schmitt, H
    Buysschaert, M
    DIABETES, 2002, 51 : A101 - A101
  • [7] Intravenous administration of insulin lispro versus regular insulin in patients with type 1 diabetes
    Stiller, R
    Kothny, T
    Gudat, UHK
    Anderson, JH
    Seger, M
    Johnson, RD
    Richardson, MS
    Haslbeck, M
    DIABETES, 1999, 48 : A115 - A115
  • [8] Lispro insulin compared with regular insulin in cirrhotic patients with type 2 diabetes mellitus
    Gentile, S
    Sasso, FC
    Turco, S
    DIABETOLOGIA, 1998, 41 : A243 - A243
  • [9] Ultra Rapid Lispro (URLi) accelerates insulin lispro absorption and insulin action vs lispro in patients with type 1 diabetes
    Linnebjerg, H.
    Zhang, Q.
    LaBell, E.
    Reddy, S.
    Coutant, D.
    Bowerman, S.
    Hoevelmann, U.
    Plum-Moerschel, L.
    Herbrand, T.
    Leohr, J.
    DIABETOLOGIA, 2019, 62 : S382 - S383
  • [10] Efficacy and safety of insulin glulisine and insulin lispro combined with insulin glargine in patients with Type 1 diabetes
    Prager, R
    Dreyer, M
    Robinson, A
    Busch, K
    Penfornis, A
    Souhami, E
    DIABETOLOGIA, 2004, 47 : A301 - A301
12345